News

Noting the positive momentum of China's pharmaceutical innovation in recent years, Liu called for joint research efforts from ...
Every year, horseshoe crabs are harvested for their blue blood, but alternatives are now coming through that could help ...
Anantha Chandrakasan hopes to remain MIT's go-to person for corporate partnerships, even as he takes on new responsibilities as the institute's new provost.
The Commerce Ministry said China would review and approve applications for items under export controls, while the U.S. will cancel a range of restrictive measures imposed on China.
Bayer and Tsinghua University (THU) announced that they have extended their research collaboration of 16 years by an additional three years, to further accelerate the translation of scientific ...
This includes offering learning opportunities through practical experience and co-developing a curriculum that facilitates access to innovative medicines, thereby strengthening a robust and ...
OpenAI has found evidence of China covertly using ChatGPT to create propaganda posts on social media, and to conduct digital surveillance.
After unveiling a new Max variant of its MONA M03 sedan, XPeng has officially launched it in China at an insanely low price of RMB 139,800.
The heads of two House committees have written a letter to the president of Duke University advising the North Carolina school to end its partnership with Wuhan University in China. Rep. Joh… ...
Northwest A&F University has welcomed its first batch of several hundred trainees under a Sino-Pakistan agricultural program that will send a total of 1,000 Pakistani agriculture graduates to ...
Qilu Pharmaceutical is paying 280 million Chinese yuan ($38 million) for a licensing and collaboration deal with fellow China biopharma Minghui Pharmaceutical. The pact centers on MHB088C, a B7-H3 ...
Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the ...